Search Results - "Armario Hita, José Carlos"
-
1
Real-World Clinical Experience of Dupilumab in the Treatment of Chronic Palmo-Plantar Eczema in Patients with Moderate-Severe Atopic Dermatitis: 52-Week Follow-Up
Published in Dermatitis (01-02-2024)“…Hand-foot eczema (HFE) are special locations of dermatitis, which are often associated with atopic dermatitis (AD) and have a significant negative impact on…”
Get more information
Journal Article -
2
Bimekizumab: Short-Term Effectiveness and Safety in Real Clinical Practice in Andalucia, Spain
Published in Life (Basel, Switzerland) (20-02-2024)“…: Psoriasis, a chronic inflammatory skin disease, affects 2-10% of the population globally. Bimekizumab (BMK), a monoclonal antibody targeting IL-17, is a dual…”
Get full text
Journal Article -
3
Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis
Published in Dermatology and therapy (01-01-2024)“…Introduction Lebrikizumab and dupilumab are monoclonal antibodies approved for treating moderate-to-severe atopic dermatitis (AD). Both have demonstrated…”
Get full text
Journal Article -
4
-
5
Patch testing in children with hand eczema. A 5-year multicentre study in Spain
Published in Contact dermatitis (01-10-2011)“…Background. Hand eczema is common in children, but affected children are seldom patch tested. Relatively few studies have assessed patch testing in the…”
Get full text
Journal Article -
6
-
7
Fifty‐two week follow‐up safety and effectiveness results of dupilumab treatment of moderate‐to‐severe atopic dermatitis from a retrospective, multicentric series
Published in Dermatologic therapy (01-07-2019)“…Atopic dermatitis (AD) is a chronic, systemic disease that has a multifactorial etiology, where immune system disorders and epidermal barrier dysfunction are…”
Get full text
Journal Article -
8
Treatment of atopic dermatitis with abrocitinib in real practice in Spain: efficacy and safety results from a 24‐week multicenter study
Published in International journal of dermatology (01-11-2024)“…Background Abrocitinib, a selective JAK 1 inhibitor, was recently approved in Europe. Despite its approval, real‐world data on its efficacy and safety in…”
Get full text
Journal Article -
9
Validation of a Questionnaire to Assess the Perception of Women with Atopic Dermatitis in Family Planning
Published in International journal of environmental research and public health (29-08-2022)“…Atopic dermatitis (AD) is a highly frequent chronic inflammatory skin disease. It is important to know how women with AD approach family planning together with…”
Get full text
Journal Article -
10
Nickel allergy in Spain needs active intervention
Published in Contact dermatitis (01-05-2011)Get full text
Journal Article -
11
Upadacitinib for moderate to severe atopic dermatitis
Published in Immunotherapy (01-08-2023)“…Atopic dermatitis is an inflammatory skin disease, the prevalence of which has increased in the last decade. It affects all age groups, with adult involvement…”
Get full text
Journal Article -
12
Prevalence of chronic urticaria refractory to antihistamines in Andalucia, Spain
Published in Dermatologic therapy (01-11-2020)“…Chronic urticaria (CU) has a devastating effect on the quality of life of patients who suffer from it. The objective of this study is to determine the…”
Get full text
Journal Article -
13
Mechanism, Diagnostic and Therapeutic Novelties in Dermatology: Where Are We Going?
Published in Life (Basel, Switzerland) (01-10-2024)“…Dermatology is one of the oldest specialties and yet one of the most innovative and constantly evolving ones, too [...]…”
Get full text
Journal Article -
14
Short-Term Effectiveness and Safety of Biologics and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review and Network Meta-Analysis
Published in Life (Basel, Switzerland) (06-09-2021)“…Background: Some Network Meta-analysis (NMA) has been published regarding atopic dermatitis (AD). These studies have considered drugs under investigation both…”
Get full text
Journal Article -
15
Brodalumab: short‐term effectiveness and safety in real clinical practice
Published in International journal of dermatology (01-09-2020)Get full text
Journal Article -
16
-
17
Current patch test results with the European baseline series and extensions to it from the 'European Surveillance System on Contact Allergy' network, 2007-2008
Published in Contact dermatitis (01-07-2012)“…Background. The pattern of contact sensitization to the supposedly most important allergens assembled in the baseline series differs between countries,…”
Get full text
Journal Article -
18
Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study
Published in Contact dermatitis (01-01-2018)“…Summary Background Corticosteroids are among the most commonly used topical drugs. Contact allergy to these exists, but can be easily missed. Corticosteroid…”
Get full text
Journal Article -
19
Consensus on the Clinical Approach to Moderate-to-Severe Atopic Dermatitis in Spain: A Delphi Survey
Published in Dermatology research and practice (2020)“…Background. The purpose of this study was to gather information on the current assessment and management of patients with moderate-to-severe AD in routine…”
Get full text
Journal Article -
20
Alternativa al cierre de heridas crónicas mediante injertos de Reverdin y factores de crecimiento en cirugía menor ambulatoria
Published in Gerokomos (01-03-2015)“…El cierre de heridas crónicas supone una alta tasa en cuidados de enfermería, sobre todo en heridas de difícil cicatrización, debido a la falta de respuesta a…”
Get full text
Journal Article